Pharmaceutical giant reveals it is partnering with Honeywell to develop a new inhaler propellant that has 99.9 per cent less Global Warming Potential than current models
It may be one of the most surprising sources of greenhouse gas emissions, but now pharmaceutical giant AstraZeneca thinks it has worked out to tackle the climate damage caused by respiratory inhalers....
To continue reading this article...
Join BusinessGreen
- Enjoy exclusive news, insights and analysis from Europe’s leading source of information on the green economy and business.
- Make smart, responsible business decisions with an eye on the latest regulatory and tech development
- Tap into our extensive archive of exclusive articles, news, analysis and guide
- Access to our new BusinessGreen intelligence service, providing you with
- > Exclusive in-depth case studies
- > Policy briefings, white papers and reports on market trends that are shaping the direction of the net zero transition
- > Our overnight briefing, expertly curated help you run a competitive and sustainable business
- > Online and interactive meetings with BusinessGreen’s editors to discuss the crucial stories and trends from the past month
Choose from 3 paid membership levels or start a 7-day no strings trial.
